SEARCH

SEARCH BY CITATION

References

  • Andrews, J.C., Durvasula, S. & Akhter, S.H. (1990) A framework for conceptualizing and measuring the involvement construct in advertising research. J Advertising 19, 2740.
  • Baron, R.M. & Kenny, D.A. (1986) The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51, 11731182.
  • Batra, R. & Holbrook, M.B. (1990) Developing a typology of affective response to advertising. Psychol Market 7, 1125.
  • Beuten, J., Ma, J.Z., Payne, T.J., Dupont, R.T., Quezada, P., Huang, W., Crews, K.M. & Li, M.D. (2005) Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet 139B, 7380.
  • Bhang, S.Y., Choi, S.W. & Ahn, J.H. (2010) Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci Lett 468, 711.
  • Bertolino, A., Blasi, G., Latorre, V., Rubino, V., Rampino, A., Sinibaldi, L., Caforio, G., Petruzzella, V., Pizzuti, A., Scarabino, T., Nardini, M., Weinberger, D.R. & Dallapiccola, B. (2006) Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26, 39183922.
  • Biener, L., Harris, J.E. & Hamilton, W. (2000) Impact of the Massachusetts tobacco control programme: population based trend analysis. BMJ 321, 351354.
  • Chaudhuri, A. & Buck, R. (1995) Media differences in rational and emotional responses to advertising. J Broadcast Electron 39, 109125.
  • Chen, J., Lipska, B.K., Halim, N., Ma, Q.D., Matsumoto, M., Melhem, S., Kolachana, B.S., Hyde, T.M., Herman, M.M., Apud, J., Egan, M.F., Kleinman, J.E. & Weinberger, D.R. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75, 807821.
  • Chua, H.F., Ho, S.S., Jasinska, A.J., Polk, T.A., Welsh, R.C., Liberzon, I. & Stretcher, V.J. (2011) Self-related neural response to tailored smoking-cessation messages predicts quitting. Nat Neurosci 14, 426427.
  • Colilla, S., Lerman, C., Shields, P.G., Jepson, C., Rukstalis, M., Berlin, J., DeMichele, A., Bunin, G., Strom, B.L. & Rebbeck, T.R. (2005) Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 15, 393398.
  • Colzato, L.S., Waszak, F., Nieuwenhuis, S., Posthuma, D. & Hommel, B. (2010) The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching. Neuropsychologia 48, 27642768.
  • Cools, R. & D’Esposito, M. (2011) Inverted U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69, e113e125.
  • Czubak, A., Nowakowska, E., Kus, K., Burda, K., Metelska, J., Baer-Dubowska, W. & Cichocki, M. (2009) Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep 61, 10171023.
  • Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D. & Weinberger, D.R. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98, 69176922.
  • Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. & Weinberger, D.R. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257269.
  • Everett, M. & Palmgreen, P. (1995) Influences of sensation seeking, message sensation value, and program context on effectiveness of anti-cocaine public service announcements. Health Commun 7, 225248.
  • Falk, E.B., Berkman, E.T., Mann, T., Harrison, B. & Lieberman, M.D. (2010a) Predicting persuasion-induced behavior change from the brain. J Neurosci 30, 84218424.
  • Falk, E.B., Rameson, L., Berkman, E.T., Liao, B., Kang, Y., Inagaki, T.K. & Lieberman, M.D. (2010b) The neural correlates of persuasion: a common network across cultures and media. J Cogn Neurosci 22, 24472459.
  • Fishbein, M., Hennessy, M., Kamb, M., Bolan, G.A., Hoxworth, T., Iatesta, M., Rhodes, F., Zenilman, J.M. & Project Respect Study Group. (2001) Using intervention theory to model factors influencing behavior change. Project RESPECT. Eval Health Prof 24, 363384.
  • Gasic, G.P., Smoller, J.W., Perlis, R.H., Sun, M., Lee, S., Kim, B.W., Lee, M.J., Holt, D.J., Blood, A.J., Makris, N., Kennedy, D.K., Hoge, R.D., Calhoun, J., Fava, M., Gusella, J.F. & Breiter, H.C. (2009) BDNF, relative preference, and reward circuitry responses to emotional communication. Am J Med Genet Part B 150B, 762781.
  • Goldberg, T.E., Egan, M.F., Gscheidle, T., Coppola, R., Weickert, T., Kolachana, B.S., Goldman, D. & Weinberger, D.R. (2003) Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psych 60, 889896.
  • Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F. & Weinberger, D.R. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 66906694.
  • Hashimoto, R., Moriguchi, Y., Yamashita, F., Mori, T., Nemoto, K., Okada, T., Hori, H., Noguchi, H., Kunugi, H. & Ohnishi, T. (2008) Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res 61, 360367.
  • Heatherton, T.F., Kozlowski, L.T., Frecker, R.C. & Fagerstrom, K.O. (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86, 11191127.
  • Heishman, S.J., Kleykamp, B.A. & Singleton, E.G. (2010) Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210, 453469.
  • Kang, J.I., Namkoong, K., Ha, R.Y., Jhung, K., Kim, Y.T. & Kim, S.J. (2010) Influence of BDNF and COMT polymorphisms on emotional decision making. Neuropharmacology 58, 11091113.
  • Lang, U.E., Sander, T., Lohoff, F.W., Hellweg, R., Bajbouj, M., Winterer, G. & Gallinat, J. (2007) Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) 190, 433439.
  • Langleben, D.D., Loughead, J.W., Ruparel, K., Hakun, J.G., Busch-Winokour, S., Holloway, M.B., Strasser, A.A., Cappella, J.N. & Lerman, C. (2009) Reduced prefrontal and temporal processing and recall of high “sensation value” ads. NeuroImage 46, 219225.
  • Lerman, C., Gold, K., Audrain, J., Lin, T.H., Boyd, N.R., Orleans, C.T., Wilfond, B., Louben, G. & Caporaso, N. (1997) Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol 16, 8799. 1.
  • Leshner, G. & Cheng, I.H. (2009) The effects of frame, appeal, and outcome extremity of antismoking messages on cognitive processing. Health Commun 24, 219227. 3.
  • Leventhal, A.M., Waters, A.J., Moolchan, E.T., Heishman, S.J. & Pickworth, W.B. (2010) A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome. Addict Behav 35, 11201130.
  • Loughead, J., Wileyto, E.P., Valdez, J.N., Sanborn, P., Tang, K., Strasser, A.A., Ruparel, K., Ray, R., Gur, R.C. & Lerman, C. (2009) Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry 14, 820826.
  • MacKinnon, D.P., Taborga, M.P. & Morgan-Lopez, A.A. (2002) Mediation designs for tobacco prevention research. Drug Alcohol Depend 68, S69S83.
  • Messer, K., Pierce, J.P., Zhu, S.H., Hartman, A.M., Al-Delaimy, W.K., Trinidad, D.R. & Gilpin, E.A. (2007) The California Tobacco Control Program's effect on adult smokers: (1) smoking cessation. Tob Control 16, 8590.
  • Montag, C., Basten, U., Stelzel, C., Fiebach, C.J. & Reuter, M. (2008) The BDNF Val66Met polymorphism and smoking. Neurosci Lett 442, 3033.
  • Morgan, S.E., Palmgreen, P., Stephenson, M.T., Lorch, E.P. & Huyle, R.H. (2003) The relationship between message sensation value and perceived message sensation value: the effect of formal message features on subjective evaluations of anti-drug public service announcements. J Commun 53, 512526.
  • Nedic, G., Nikolac, M., Borovecki, F., Hajnsek, S., Muck-Seler, D. & Pivac, N. (2010) Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neurosci Lett 473, 216219.
  • Novak, G., LeBlanc, M., Zai, C., Shaikh, S., Renou, J., DeLuca, V., Bulgin, N., Kennedy, J.L. & Le Foll, B. (2010) Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 74, 291298.
  • Norman, P., Conner, M. & Bell, R. (1999) The theory of planned behavior and smoking cessation. Health Psychol 18, 8994.
  • Palmatier, M.A., Kang, A.M. & Kidd, K.K. (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46, 557567.
  • Palmgreen, P., Stephenson, M.T., Everett, M.W., Baseheart, J.R. & Francies, R. (2002) Perceived message sensation value (PMSV) and the dimensions and validation of a PMSV scale. Health Commun 1 4, 403428.
  • Petryshen, T.L., Sabeti, P.C., Aldinger, K.A., Fry, B., Fan, J.B., Schaffner, S.F., Waggoner, S.G., Tahl, A.R. & Sklar, P. (2010) Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Mol Psychiatry 15, 810815.
  • Pomarol-Clotet, E., Fatjó-Vilas, M., McKenna, P.J., Monté, G.C., Sarró, S., Ortiz-Gil, J., Aguirre, C., Gomar, J.J., Guerrero, A., Landin, R., Capdevila, A., Fañanás, L. & Salvador, R. (2010) COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: a study in patients with schizophrenia and healthy subjects. NeuroImage 53, 899907.
  • Rybakowski, J.K., Borkowska, A., Czerski, P.M., Skibinska, M. & Hauser, J. (2003) Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5, 468472.
  • Savitz, J., Solms, M. & Ramesar, R. (2006) The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav 5, 311328.
  • Schofield, P.R., Williams, L.M., Paul, R.H., Gatt, J.M., Brown, K., Luty, A., Cooper, N., Grieve, S., Dobson-Stone, C., Morris, C., Kuan, S.A. & Gordon, E. (2009) Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems. Biol Psychol 80, 176188.
  • Siegel, M. (1998) Mass media antismoking campaigns: a powerful tool for health promotion. Ann Intern Med 129, 128132.
  • Strasser, A.A., Cappella, J.N., Jepson, C., Fishbein, M., Tang, K.Z., Han, E. & Lerman, C. (2009) Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. Nicotine Tob Res 11, 293302.
  • World Health Organization. (2009) WHO report on the global tobacco epidemic: Implementing smoke free environments. Geneva, World Health Organization.
  • Yzer, M.C., Cappella, J.N., Fishbein, M., Hornik, R. & Ahern, R.K. (2003) The effectiveness of gateway communications in anti-marijuana campaigns. J Health Commun 8, 129143.
  • Zhao, X., Strasser, A.A., Cappella, J.N., Lerman, C. & Fishbein, M. (2011) A measure of perceived argument strength: reliability and validity in health communication contexts. Commun Methods Measures 5, 4875.